Sintalica Corp.
  • Home
  • About
  • Contact
  • News
  • More
    • Home
    • About
    • Contact
    • News
Sintalica Corp.
  • Home
  • About
  • Contact
  • News

About Us

Sintalica is an integrated drug discovery company using psychedelics to help patients suffering from neuroinflammatory disorders. 


We are uniquely specialized in synthesizing new proprietary psychedelic molecules with improved safety profiles. 


Our scientific team is led by world-class experts in neurodegenerative diseases, pharmacology and chemistry. 


We have partnered with the University of Messina, where we develop valuable intellectual property, synthesize active compounds and conduct trials.

Leadership Team

Bruce Linton

Olivier Dufourmantelle

Sergio Martines

CHAIRMAN


Founder, Chairman and CEO of Collective Growth Corp.

Board of Directors for Mind Medicine Inc.

Executive Chairman for Gage Cannabis Co.

Chairman of the Advisory Board for Red Light Holland Corp.

Co-founder and Chairman of Óskare Capital

Board of Directors of the Canadian Olympic Foundation

Co-Chairman and CEO of Martello Technologies 

Co

CHAIRMAN


Founder, Chairman and CEO of Collective Growth Corp.

Board of Directors for Mind Medicine Inc.

Executive Chairman for Gage Cannabis Co.

Chairman of the Advisory Board for Red Light Holland Corp.

Co-founder and Chairman of Óskare Capital

Board of Directors of the Canadian Olympic Foundation

Co-Chairman and CEO of Martello Technologies 

Co‐founder and Chairman of Ruckify

Founder, Chairman and CEO of Canopy Growth Corp. 

Sergio Martines

Olivier Dufourmantelle

Sergio Martines

CEO/DIRECTOR


Founder and CEO of Canapar Corp for the cultivation and extraction of cannabinoids.

Extensive international entrepreneurship within the pharmaceutical, dermo-cosmetic and nutritional fields, with over thirty years of experience in development to the commercialization of consumer products among fast emerging markets.

Olivier Dufourmantelle

Olivier Dufourmantelle

Olivier Dufourmantelle

PRESIDENT/DIRECTOR


Co-Founder and President of Galaxie Brands Corp. 

President US and Board of  Director of TGOD Cannabis Inc. 

COO of Canopy Growth Corp.

COO of Canopy Rivers

Engagement Manager McKinsey & Company

General Manager Michelin Europe and Asia 

Board of Directors Canapar Corp.

P.Eng designation, MBA from Harvard Business School.

Peter Kampian

Olivier Dufourmantelle

Olivier Dufourmantelle

CFO

Director and Audit Committee Chair of Audro Clean Technologies Inc.

Director and Audit Committee Chair of Greenbutts Canada Holdings Inc.

Director and Audit Committee Chair of Harborside Inc.

CFO Electron Inc. 

CFO of Algonquin Income Fund CFO of Mettrum Health Corp. CPA, CA and  ICD.D designation Business graduate of Wilfrid Laurier University.


Jason Monaco

Judy Ashworth, M.D.

Judy Ashworth, M.D.

DIRECTOR


CEO and Founder of the First Canadian Group of Companies.

Specializes in providing full-service financial

solutions in the disciplines of Investment Banking, Investor Relations, Investment Management, AssetBacked Lending, and Real Estate Development. 

Board of Directors of Zonte Metals Inc., CT Developers Ltd., and Oriana Resources Corp. 

Judy Ashworth, M.D.

Judy Ashworth, M.D.

Judy Ashworth, M.D.

SCIENTIFIC ADVISOR


VP of Rx Strategic Services 

CMO, Pinney Associates, Inc.  

Clinical development and regulatory strategist with over 20 years pharmaceutical industry experience developing CNS-active drugs, including psychedelics.

David Heal, Ph.D.

Judy Ashworth, M.D.

David Heal, Ph.D.

SCIENTIFIC ADVISOR


Co-Founder and Executive Director DevelRx Ltd  

Co-founder and Director of non-clinical CRO, RenaSci

Extensive career in senior roles the pharmaceutical industry and academia including supporting the registration of 12 novel CNS drugs in various psychiatric and neurological indications.  

Visiting Professor in the Departmen

SCIENTIFIC ADVISOR


Co-Founder and Executive Director DevelRx Ltd  

Co-founder and Director of non-clinical CRO, RenaSci

Extensive career in senior roles the pharmaceutical industry and academia including supporting the registration of 12 novel CNS drugs in various psychiatric and neurological indications.  

Visiting Professor in the Department of Pharmacy and Pharmacology, University of Bath.  Fellow of the Royal Society of Chemistry

Fellow of the British Pharmacological Society

Member of the American College of Neuropsychopharmacology.  Authored more than 200 publications.

Scientific Team

Salvatore Cuzzocrea

Salvatore Cuzzocrea

Salvatore Cuzzocrea

HEAD OF PHARMACOLOGY


Rector of the University of Messina.

Professor of Pharmacology, School of Medicine, University of Messina.
Former honorary Professor of Pharmacology in the University of Manchester (UK).
Authored more than 600 publications including articles in peer reviewed international journals and scientific books. Editor and refe

HEAD OF PHARMACOLOGY


Rector of the University of Messina.

Professor of Pharmacology, School of Medicine, University of Messina.
Former honorary Professor of Pharmacology in the University of Manchester (UK).
Authored more than 600 publications including articles in peer reviewed international journals and scientific books. Editor and referee for several international journals.
Research activities in the field of autoimmunity, inflammation and neurodegenerative disorders as well as drug development.

Luigi Mondello

Salvatore Cuzzocrea

Salvatore Cuzzocrea

HEAD OF ANALYTICAL CHEMISTRY

  

Professor of Analytical Chemistry at the Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina.
Authored more than 465 publications.
In the list of the “Top Italian Scientist", included in the “Power List” among the top 100 most influential people in the analytical sciences 2

HEAD OF ANALYTICAL CHEMISTRY

  

Professor of Analytical Chemistry at the Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina.
Authored more than 465 publications.
In the list of the “Top Italian Scientist", included in the “Power List” among the top 100 most influential people in the analytical sciences 2013 and 2015 by The Analytical Scientist Journal.
Included in the top 10 worldwide scientists in the field of Separation Science in 2017 by the Analytical Scientist Journal.

Mitch Earleywine

Salvatore Cuzzocrea

Marcella Marletta

CHIEF MEDICAL OFFICER

  

Professor of Psychology at University at Albany, State University of New York.
Lead a research program in the Habits and Lifestyle Laboratory focusing on the study of personality, drug use, and addictive behaviors.
Co-developed Integrative Ketamine Enhanced Psychotherapy (iKEP; De Leo & Earleywine, 2019).
Authored

CHIEF MEDICAL OFFICER

  

Professor of Psychology at University at Albany, State University of New York.
Lead a research program in the Habits and Lifestyle Laboratory focusing on the study of personality, drug use, and addictive behaviors.
Co-developed Integrative Ketamine Enhanced Psychotherapy (iKEP; De Leo & Earleywine, 2019).
Authored more than 200 publications.
Advisory board member of the National Organization for Reformation of Marijuana Laws (NORML).

Marcella Marletta

Salvatore Cuzzocrea

Marcella Marletta

HEAD OF REGULATORY AFFAIRS

  

General director of the Department of Medicines and Medical Devices of the Italian Ministry of Health.
Surgeon and specialist in Ophthalmology.
Professor of Pharmacology, Pathology and Regulatory Sciences at the San Raffaele University in Rome.
Member of the Ethics Committee for clinical trials in the Gemelli 

HEAD OF REGULATORY AFFAIRS

  

General director of the Department of Medicines and Medical Devices of the Italian Ministry of Health.
Surgeon and specialist in Ophthalmology.
Professor of Pharmacology, Pathology and Regulatory Sciences at the San Raffaele University in Rome.
Member of the Ethics Committee for clinical trials in the Gemelli Polyclinic of the Catholic University of the Sacred Heart of Rome and the Ethics Committee for clinical trials of the Tor Vergata University of Rome.
Authored more than 200 publications. 

Luca Santi

Rosanna Di Paola

Luca Santi

HEAD OF BIOTECHNOLOGY

  

Associate Professor in Pharmaceutical Biology, University of Tuscia. 

Researched and teached at the University of Galway in Ireland, the Max Planck institute of Cologne in Germany

Former Assistant Professor of Plant Biotechnology at the Arizona State University

Authored more than 56 publications. 

Anna Notti

Rosanna Di Paola

Luca Santi

HEAD OF ORGANIC SYNTHESIS


Professor of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina Member of the Italian Chemical Society.
Authored more than 70 publications. 

Rosanna Di Paola

Rosanna Di Paola

Rosanna Di Paola

HEAD OF PRE-CLINICAL PHARMACOLOGY


Associate Professor of Biochemistry at the Chemical, Biological, Pharmaceutical and Environmental Science.
Authored more than 300 publication.

Ilaria Cacciotti

Rosanna Di Paola

Rosanna Di Paola

HEAD OF FORMULATION AND DELIVERY

  

Professor of Biomaterials & Tissue Engineering and Materials Science & Technology at University of Rome "Niccolò Cusano"

Member of the Research and Projects Committee. 

  • Privacy Policy
  • Terms and Conditions

Sintalica Bioscience Corp.

100 King Street West, Toronto, Ontario M5X 2A2, Canada

Copyright © 2022 Sintalica Corp. - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept